Healthcare Infection Control Practices Advisory Committee

---
identifier: "/us/fr/04-3424"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Healthcare Infection Control Practices Advisory Committee"
title_number: 0
title_name: "Federal Register"
section_number: "04-3424"
section_name: "Healthcare Infection Control Practices Advisory Committee"
positive_law: false
currency: "2004-02-18"
last_updated: "2004-02-18"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "04-3424"
document_type: "notice"
publication_date: "2004-02-18"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "69 FR 7640"
fr_volume: 69
---


#  Healthcare Infection Control Practices Advisory Committee

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (P.L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting.

*Name:* Healthcare Infection Control Practices Advisory Committee meeting.

*Times and Dates:*

8:30 a.m.—5 p.m., March 4, 2004.

8:30 a.m.—4 p.m., March 5, 2004.

*Place:* Westin Peachtree Plaza, 210 Peachtree St. NW., Atlanta, GA 30303.

*Status:* Open to the public, limited only by the space available.

*Purpose:* The Committee is charged with providing advice and guidance to the Secretary, the Assistant Secretary for Health, the Director, CDC, and the Director, National Center for Infectious Diseases (NCID), regarding: (1) The practice of hospital infection control; (2) strategies for surveillance, prevention, and control of infections ( *e.g.,* nosocomial infections), antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions.

*Matters To Be Discussed:* Agenda items will include an overview of issues related to public reporting of nosocomial infection rates; healthcare preparedness; influenza (avian and human); infection control in ambulatory care settings; strategies for surveillance of healthcare-associated infections; and updates on CDC activities of interest to the committee.

Agenda items are subject to change as priorities dictate.

*For Further Information Contact:* Michele L. Pearson,M.D., Executive Secretary, HICPAC, Division of Healthcare Quality Promotion, NCID, CDC, 1600 Clifton Road, NE., M/S A-07, Atlanta, Georgia 30333, telephone 404/498-1182.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: February 11, 2004.

Alvin Hall,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.